DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival. (October 2018)
- Record Type:
- Journal Article
- Title:
- DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival. (October 2018)
- Main Title:
- DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival
- Authors:
- Ambatipudi, Srikant
Langdon, Ryan
Richmond, Rebecca C.
Suderman, Matthew
Koestler, Devin C.
Kelsey, Karl T.
Kazmi, Nabila
Penfold, Christopher
Ho, Karen M.
McArdle, Wendy
Ring, Susan M.
Pring, Miranda
Waterboer, Tim
Pawlita, Michael
Gaunt, Tom R.
Davey Smith, George
Thomas, Steve
Ness, Andy R.
Relton, Caroline L. - Abstract:
- Highlights: DNA methylation data was used to derive systemic inflammation indices. Elevated mdNLR and lower mdLMR were associated with the risk of HNSCC. HPV16-E6 seropositive HNSCCs had an elevated mdLMR and a lower mdNLR. Lower mdLMR was associated with increased risk of death. Abstract: Objectives: Head and neck squamous cell carcinoma (HNSCC) is often associated with chronic systemic inflammation (SI). In the present study, we assessed if DNA methylation-derived SI (mdSI) indices: Neutrophil-to-Lymphocyte ratio (mdNLR) and Lymphocyte-to-Monocyte ratio (mdLMR) are associated with the presence of HNSCC and overall survival (OS). Materials and methods: We used two peripheral blood DNA methylation datasets: an HNSCC case-control dataset (n = 183) and an HNSCC survival dataset (n = 407) to estimate mdSI indices. We then performed multivariate regressions to test the association between mdSI indices, HNSCC development and OS. Results: Multivariate logistic regression revealed that elevated mdNLR was associated with increased odds of being an HNSCC case (OR = 3.25, 95% CI = 2.14–5.34, P = 4 × 10 −7 ) while the converse was observed for mdLMR (OR = 0.88, 95% CI = 0.81–0.90, P = 2 × 10 −3 ). In the HNSCC survival dataset, HPV16-E6 seropositive HNSCC cases had an elevated mdLMR ( P = 9 × 10 −5 ) and a lower mdNLR ( P = 0.003) compared to seronegative patients. Multivariate Cox regression in the HNSCC survival dataset revealed that lower mdLMR (HR = 1.96, 95% CI = 1.30–2.95, PHighlights: DNA methylation data was used to derive systemic inflammation indices. Elevated mdNLR and lower mdLMR were associated with the risk of HNSCC. HPV16-E6 seropositive HNSCCs had an elevated mdLMR and a lower mdNLR. Lower mdLMR was associated with increased risk of death. Abstract: Objectives: Head and neck squamous cell carcinoma (HNSCC) is often associated with chronic systemic inflammation (SI). In the present study, we assessed if DNA methylation-derived SI (mdSI) indices: Neutrophil-to-Lymphocyte ratio (mdNLR) and Lymphocyte-to-Monocyte ratio (mdLMR) are associated with the presence of HNSCC and overall survival (OS). Materials and methods: We used two peripheral blood DNA methylation datasets: an HNSCC case-control dataset (n = 183) and an HNSCC survival dataset (n = 407) to estimate mdSI indices. We then performed multivariate regressions to test the association between mdSI indices, HNSCC development and OS. Results: Multivariate logistic regression revealed that elevated mdNLR was associated with increased odds of being an HNSCC case (OR = 3.25, 95% CI = 2.14–5.34, P = 4 × 10 −7 ) while the converse was observed for mdLMR (OR = 0.88, 95% CI = 0.81–0.90, P = 2 × 10 −3 ). In the HNSCC survival dataset, HPV16-E6 seropositive HNSCC cases had an elevated mdLMR ( P = 9 × 10 −5 ) and a lower mdNLR ( P = 0.003) compared to seronegative patients. Multivariate Cox regression in the HNSCC survival dataset revealed that lower mdLMR (HR = 1.96, 95% CI = 1.30–2.95, P = 0.0013) but not lower mdNLR (HR = 0.68, 95% CI = 0.46–1.00, P = 0.0501) was associated with increased risk of death. Conclusion: Our results indicate that mdSI estimated by DNA methylation data is associated with the presence of HNSCC and overall survival. The mdSI indices may be used as a valuable research tool to reliably estimate SI in the absence of cell-based estimates. Rigorous validation of our findings in large prospective studies is warranted in the future. … (more)
- Is Part Of:
- Oral oncology. Volume 85(2018)
- Journal:
- Oral oncology
- Issue:
- Volume 85(2018)
- Issue Display:
- Volume 85, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 85
- Issue:
- 2018
- Issue Sort Value:
- 2018-0085-2018-0000
- Page Start:
- 87
- Page End:
- 94
- Publication Date:
- 2018-10
- Subjects:
- Head and neck cancer -- Systemic inflammation -- DNA methylation -- Neutrophil-to-lymphocyte ratio -- Lymphocyte-to-monocyte ratio -- Overall survival -- mdNLR
mdNLR Methylation derived Neutrophil-to-Lymphocyte Ratio -- mdLMR Methylation derived Lymphocyte-to-Monocyte Ratio
Mouth -- Cancer -- Periodicals
Mouth -- Tumors -- Periodicals
Mouth Diseases -- Periodicals
Mouth Neoplasms -- Periodicals
Bouche -- Cancer -- Périodiques
Bouche -- Tumeurs -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9943105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/13688375 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/13688375 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.oraloncology.2018.08.021 ↗
- Languages:
- English
- ISSNs:
- 1368-8375
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6277.592000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10882.xml